Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age

por Tesser, John, Kafka, Shelly, DeHoratius, Raphael J., Xu, Stephen, Hsia, Elizabeth C., Turkiewicz, Anthony
Publicado 2019

Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2

por McInnes, Iain B, Chakravarty, Soumya D, Apaolaza, Isabel, Kafka, Shelly, Hsia, Elizabeth C, You, Yin, Kavanaugh, Arthur
Publicado 2019

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses...

por Smolen, Josef S, Kay, Jonathan, Matteson, Eric L, Landewé, Robert, Hsia, Elizabeth C, Xu, Stephen, Zhou, Yiying, Doyle, Mittie K
Publicado 2014

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoi...

por Kay, Jonathan, Fleischmann, Roy, Keystone, Edward, Hsia, Elizabeth C, Hsu, Benjamin, Mack, Michael, Goldstein, Neil, Braun, Jürgen, Kavanaugh, Arthur
Publicado 2015

Safety and Efficacy of Intravenous Golimumab in Patients With Active Psoriatic Arthritis: Results Through Week Twenty‐Four of the GO‐VIBRANT Study

por Kavanaugh, Arthur, Husni, M. Elaine, Harrison, Diane D., Kim, Lilianne, Lo, Kim Hung, Leu, Jocelyn H., Hsia, Elizabeth C.
Publicado 2017

Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial

por Conaghan, Philip G, Emery, Paul, Østergaard, Mikkel, Keystone, Edward C, Genovese, Mark C, Hsia, Elizabeth C, Xu, Weichun, Rahman, Mahboob U
Publicado 2011

Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study

por Deodhar, Atul A., Shiff, Natalie J., Gong, Cinty, Hsia, Elizabeth C., Lo, Kim Hung, Kim, Lilliane, Xu, Stephen, Reveille, John D.
Publicado 2022

Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study

por Deodhar, Atul, Chakravarty, Soumya D., Shiff, Natalie J., Lo, Kim Hung, Xu, Stephen, Hsia, Elizabeth C., Danve, Abhijeet, Reveille, John D.
Publicado 2022

Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study...

por Mease, Philip, Elaine Husni, M., Chakravarty, Soumya D., Kafka, Shelly, Parenti, Dennis, Kim, Lilianne, Hung Lo, Kim, Hsia, Elizabeth C., Kavanaugh, Arthur
Publicado 2020

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

por Kirkham, Bruce W, Wasko, Mary Chester, Hsia, Elizabeth C, Fleischmann, Roy M, Genovese, Mark C, Matteson, Eric L, Liu, Hongjuan, Rahman, Mahboob U
Publicado 2014

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: res...

por Mease, Philip, Husni, M. Elaine, Kafka, Shelly, Chakravarty, Soumya D., Harrison, Diane D., Lo, Kim Hung, Xu, Stephen, Hsia, Elizabeth C., Kavanaugh, Arthur
Publicado 2020

Efficacy and Safety of Intravenous Golimumab Through One Year in Patients With Active Psoriatic Arthritis

por Husni, M. Elaine, Kavanaugh, Arthur, Murphy, Frederick, Rekalov, Dmytro, Harrison, Diane D., Kim, Lilianne, Lo, Kim Hung, Leu, Jocelyn H., Hsia, Elizabeth C.
Publicado 2020

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

por Husni, M. Elaine, Deodhar, Atul, Schwartzman, Sergio, Chakravarty, Soumya D., Hsia, Elizabeth C., Leu, Jocelyn H., Zhou, Yiying, Lo, Kim H., Kavanaugh, Arthur
Publicado 2022

Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, rand...

por Smolen, Josef S, Kay, Jonathan, Doyle, Mittie, Landewé, Robert, Matteson, Eric L, Gaylis, Norman, Wollenhaupt, Jürgen, Murphy, Frederick T, Xu, Stephen, Zhou, Yiying, Hsia, Elizabeth C
Publicado 2015

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, doub...

por Smolen, Josef S, Kay, Jonathan, Landewé, Robert B M, Matteson, Eric L, Gaylis, Norman, Wollenhaupt, Jurgen, Murphy, Frederick T, Zhou, Yiying, Hsia, Elizabeth C, Doyle, Mittie K
Publicado 2012

Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial

por Helliwell, Philip S., Deodhar, Atul, Gottlieb, Alice B., Boehncke, Wolf-Henning, Xu, Xie L., Xu, Stephen, Wang, Yuhua, Hsia, Elizabeth C., Gladman, Dafna D., Ritchlin, Christopher T.
Publicado 2020

Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study

por Deodhar, Atul, Shiff, Natalie J., Gong, Cinty, Chan, Eric K. H., Hsia, Elizabeth C., Lo, Kim Hung, Akawung, Alianu, Kim, Lilianne, Xu, Stephen, Reveille, John D.
Publicado 2023

Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo‐Controlled Trials

por Siebert, Stefan, Sweet, Kristen M., Ritchlin, Christopher T., Hsia, Elizabeth C., Kollmeier, Alexa P., Xu, Xie L., Seridi, Loqmane, Song, Qingxuan, Gao, Sheng, Chen, Warner, Miron, Michelle
Publicado 2023

Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis

por Emery, Paul, van der Heijde, Désirée, Østergaard, Mikkel, Conaghan, Philip G, Genovese, Mark C, Keystone, Edward C, Fleischmann, Roy, Hsia, Elizabeth C, Xu, Weichun, Xu, Stephen, Rahman, Mahboob U
Publicado 2011

Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response—results from two phase 3 clinical trials of 1120 patients with ac...

por Rahman, Proton, Mease, Philip J., Helliwell, Philip S., Deodhar, Atul, Gossec, Laure, Kavanaugh, Arthur, Kollmeier, Alexa P., Hsia, Elizabeth C., Zhou, Bei, Lin, Xiwu, Shawi, May, Karyekar, Chetan S., Han, Chenglong
Publicado 2021